JPM UK Equity Growth Fund B - Net IncomeRegister to Unlock Ratings |
Performance History | 31/12/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | -5.3 | 19.0 | -13.1 | 11.2 | 12.7 | |
+/-Cat | -0.3 | 2.7 | -1.4 | 3.2 | 4.9 | |
+/-B’mrk | - | - | - | 3.6 | 2.9 | |
Category: UK Flex-Cap Equity | ||||||
Category Benchmark: Morningstar UK All Cap TME ... |
Key Stats | ||
NAV 21/01/2025 | GBP 1.91 | |
Day Change | 0.63% | |
Morningstar Category™ | UK Flex-Cap Equity | |
IA (formerly IMA) Sector | UK All Companies | |
ISIN | GB00B3FJQC62 | |
Fund Size (Mil) 21/01/2025 | GBP 157.33 | |
Share Class Size (Mil) 21/01/2025 | GBP 0.34 | |
Max Initial Charge | - | |
Ongoing Charge 01/01/2024 | 1.15% |
Investment Objective: JPM UK Equity Growth Fund B - Net Income |
To provide capital growth over the long-term (5-10 years) by investing at least 80% of the Fund's assets in a growth style biased portfolio of UK companies. At least 80% of assets invested in a growth style biased portfolio of equities of companies that are domiciled, or carrying out the main part of their economic activity, in the UK. |
Returns | ||||||||||||||||
|
Management | ||
Manager Name Start Date | ||
Guy Anderson 31/05/2021 | ||
Manasij Hajra 01/02/2023 | ||
Inception Date 03/05/2019 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE All Share NR GBP | Morningstar UK All Cap TME NR GBP |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for JPM UK Equity Growth Fund B - Net Income | 31/12/2024 |
|
|
Top 5 Holdings | Sector | % |
AstraZeneca PLC | Healthcare | 5.35 |
Unilever PLC | Consumer Defensive | 5.34 |
3i Group Ord | 4.81 | |
Shell PLC | Energy | 4.22 |
HSBC Holdings PLC | Financial Services | 4.01 |
Increase Decrease New since last portfolio | ||
JPM UK Equity Growth Fund B - Net Income |